(Q59537968)

English

Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP–EBMT analysis

scientific article published on 04 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Annalisa Ruggeri

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Christina Peters

18

object named as

C Peters

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

G Michel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J-H Dalle

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Caniglia

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

F Locatelli

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

A Campos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

C D de Heredia

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Mohty

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J M P Hurtado

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Bierings

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

H Bittencourt

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Mauad

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

D Purtill

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

N Kabbara

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

E Gluckman

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Labopin

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

V Rocha

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

4 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2455-2461

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

https://scigraph.springernature.com/pub.10.1038/leu.2012.123

0 references

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Searching for alternative hematopoietic stem cell donors for pediatric patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic minimal residual disease detection in acute lymphoblastic leukemia: a comparative approach to molecular testing

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

New markers for minimal residual disease detection in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

'Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)'

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2012.123

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22555150%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q59537968&oldid=2098352994"